# Study on Costs and Safety of Early Conversion From Intravenous to Oral Antibiotic Treatment in Patients With Severe Community-Acquired Pneumonia

> **NCT00273676** · PHASE4 · COMPLETED · sponsor: **UMC Utrecht** · enrollment: 500 (—)

## Conditions studied

- Severe Communtity-Acquired Pneumonia

## Interventions

- **PROCEDURE:** Conversion to oral antibiotic treatment after 3 days of intravenous antibiotic treatment

## Key facts

- **NCT ID:** NCT00273676
- **Lead sponsor:** UMC Utrecht
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-07
- **Primary completion:** —
- **Final completion:** 2004-03
- **Target enrollment:** 500 (—)
- **Last updated:** 2006-01-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00273676

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00273676, "Study on Costs and Safety of Early Conversion From Intravenous to Oral Antibiotic Treatment in Patients With Severe Community-Acquired Pneumonia". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00273676. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*